←back to thread

129 points jxmorris12 | 1 comments | | HN request time: 0s | source
Show context
consumer451 ◴[] No.43131341[source]
Satya Nadella on AGI:

> Before I get to what Microsoft's revenue will look like, there's only one governor in all of this. This is where we get a little bit ahead of ourselves with all this AGI hype. Remember the developed world, which is what? 2% growth and if you adjust for inflation it’s zero?

> So in 2025, as we sit here, I'm not an economist, at least I look at it and say we have a real growth challenge. So, the first thing that we all have to do is, when we say this is like the Industrial Revolution, let's have that Industrial Revolution type of growth.

> That means to me, 10%, 7%, developed world, inflation-adjusted, growing at 5%. That's the real marker. It can't just be supply-side.

> In fact that’s the thing, a lot of people are writing about it, and I'm glad they are, which is the big winners here are not going to be tech companies. The winners are going to be the broader industry that uses this commodity that, by the way, is abundant. Suddenly productivity goes up and the economy is growing at a faster rate. When that happens, we'll be fine as an industry.

> But that's to me the moment... us self-claiming some AGI milestone, that's just nonsensical benchmark hacking to me. The real benchmark is: the world growing at 10%.

https://www.dwarkeshpatel.com/p/satya-nadella

replies(5): >>43131406 #>>43131690 #>>43132200 #>>43132599 #>>43132719 #
1. LarsDu88 ◴[] No.43132599[source]
As someone who works in the AI/ML field, but somewhat in a biomedical space, this is promising to hear.

The core technology is becoming commoditized. The ability to scale is also becoming more and more commoditized by the day. Now we have the capability to truly synthesize the world's biomedical literature and combine it with technologies like single cell sequencing to deliver on some really amazing pharmaceutical advances over the next few years.